344 related articles for article (PubMed ID: 19741495)
1. S(+)-ketamine effect on experimental pain and cardiac output: a population pharmacokinetic-pharmacodynamic modeling study in healthy volunteers.
Sigtermans M; Dahan A; Mooren R; Bauer M; Kest B; Sarton E; Olofsen E
Anesthesiology; 2009 Oct; 111(4):892-903. PubMed ID: 19741495
[TBL] [Abstract][Full Text] [Related]
2. The dose-dependent effect of S(+)-ketamine on cardiac output in healthy volunteers and complex regional pain syndrome type 1 chronic pain patients.
Olofsen E; Sigtermans M; Noppers I; Niesters M; Mooren R; Bauer M; Aarts L; Sarton E; Dahan A
Anesth Analg; 2012 Sep; 115(3):536-46. PubMed ID: 22575567
[TBL] [Abstract][Full Text] [Related]
3. Exploring the pharmacokinetics of oral ketamine in children undergoing burns procedures.
Brunette KE; Anderson BJ; Thomas J; Wiesner L; Herd DW; Schulein S
Paediatr Anaesth; 2011 Jun; 21(6):653-62. PubMed ID: 21355949
[TBL] [Abstract][Full Text] [Related]
4. Effects of low-dose intranasal (S)-ketamine in patients with neuropathic pain.
Huge V; Lauchart M; Magerl W; Schelling G; Beyer A; Thieme D; Azad SC
Eur J Pain; 2010 Apr; 14(4):387-94. PubMed ID: 19733106
[TBL] [Abstract][Full Text] [Related]
5. Modeling the norketamine metabolite in children and the implications for analgesia.
Herd DW; Anderson BJ; Holford NH
Paediatr Anaesth; 2007 Sep; 17(9):831-40. PubMed ID: 17683400
[TBL] [Abstract][Full Text] [Related]
6. Effect of subanesthetic ketamine on intrinsic functional brain connectivity: a placebo-controlled functional magnetic resonance imaging study in healthy male volunteers.
Niesters M; Khalili-Mahani N; Martini C; Aarts L; van Gerven J; van Buchem MA; Dahan A; Rombouts S
Anesthesiology; 2012 Oct; 117(4):868-77. PubMed ID: 22890117
[TBL] [Abstract][Full Text] [Related]
7. Stereoselective ketamine effect on cardiac output: a population pharmacokinetic/pharmacodynamic modelling study in healthy volunteers.
Kamp J; van Velzen M; Aarts L; Niesters M; Dahan A; Olofsen E
Br J Anaesth; 2021 Jul; 127(1):23-31. PubMed ID: 33896589
[TBL] [Abstract][Full Text] [Related]
8. Effect of rifampicin on S-ketamine and S-norketamine plasma concentrations in healthy volunteers after intravenous S-ketamine administration.
Noppers I; Olofsen E; Niesters M; Aarts L; Mooren R; Dahan A; Kharasch E; Sarton E
Anesthesiology; 2011 Jun; 114(6):1435-45. PubMed ID: 21508826
[TBL] [Abstract][Full Text] [Related]
9. Differential modulation of remifentanil-induced analgesia and postinfusion hyperalgesia by S-ketamine and clonidine in humans.
Koppert W; Sittl R; Scheuber K; Alsheimer M; Schmelz M; Schüttler J
Anesthesiology; 2003 Jul; 99(1):152-9. PubMed ID: 12826855
[TBL] [Abstract][Full Text] [Related]
10. An observational study on the effect of S+-ketamine on chronic pain versus experimental acute pain in Complex Regional Pain Syndrome type 1 patients.
Sigtermans M; Noppers I; Sarton E; Bauer M; Mooren R; Olofsen E; Dahan A
Eur J Pain; 2010 Mar; 14(3):302-7. PubMed ID: 19540140
[TBL] [Abstract][Full Text] [Related]
11. Population pharmacokinetics of S-ketamine and norketamine in healthy volunteers after intravenous and oral dosing.
Fanta S; Kinnunen M; Backman JT; Kalso E
Eur J Clin Pharmacol; 2015 Apr; 71(4):441-7. PubMed ID: 25724645
[TBL] [Abstract][Full Text] [Related]
12. Estimation of the contribution of norketamine to ketamine-induced acute pain relief and neurocognitive impairment in healthy volunteers.
Olofsen E; Noppers I; Niesters M; Kharasch E; Aarts L; Sarton E; Dahan A
Anesthesiology; 2012 Aug; 117(2):353-64. PubMed ID: 22692377
[TBL] [Abstract][Full Text] [Related]
13. Pharmacodynamic profiles of ketamine (R)- and (S)- with 5-day inpatient infusion for the treatment of complex regional pain syndrome.
Goldberg ME; Torjman MC; Schwartzman RJ; Mager DE; Wainer IW
Pain Physician; 2010; 13(4):379-87. PubMed ID: 20648207
[TBL] [Abstract][Full Text] [Related]
14. Enantioselective pharmacokinetics of (R)- and (S)-ketamine after a 5-day infusion in patients with complex regional pain syndrome.
Goldberg ME; Torjman MC; Schwartzman RJ; Mager DE; Wainer IW
Chirality; 2011 Feb; 23(2):138-43. PubMed ID: 20803495
[TBL] [Abstract][Full Text] [Related]
15. Population pharmacokinetic-pharmacodynamic modeling of ketamine-induced pain relief of chronic pain.
Dahan A; Olofsen E; Sigtermans M; Noppers I; Niesters M; Aarts L; Bauer M; Sarton E
Eur J Pain; 2011 Mar; 15(3):258-67. PubMed ID: 20638877
[TBL] [Abstract][Full Text] [Related]
16. Modulation of remifentanil-induced analgesia, hyperalgesia, and tolerance by small-dose ketamine in humans.
Luginbühl M; Gerber A; Schnider TW; Petersen-Felix S; Arendt-Nielsen L; Curatolo M
Anesth Analg; 2003 Mar; 96(3):726-732. PubMed ID: 12598253
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic-pharmacodynamic modeling of morphine-6-glucuronide-induced analgesia in healthy volunteers: absence of sex differences.
Romberg R; Olofsen E; Sarton E; den Hartigh J; Taschner PE; Dahan A
Anesthesiology; 2004 Jan; 100(1):120-33. PubMed ID: 14695733
[TBL] [Abstract][Full Text] [Related]
18. The addition of ketamine to a morphine nurse- or patient-controlled analgesia infusion (PCA/NCA) increases analgesic efficacy in children with mucositis pain.
James PJ; Howard RF; Williams DG
Paediatr Anaesth; 2010 Sep; 20(9):805-11. PubMed ID: 20716072
[TBL] [Abstract][Full Text] [Related]
19. Mapping of punctuate hyperalgesia around a surgical incision demonstrates that ketamine is a powerful suppressor of central sensitization to pain following surgery.
Stubhaug A; Breivik H; Eide PK; Kreunen M; Foss A
Acta Anaesthesiol Scand; 1997 Oct; 41(9):1124-32. PubMed ID: 9366932
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of ketamine and its major metabolites norketamine, hydroxynorketamine, and dehydronorketamine: a model-based analysis.
Kamp J; Jonkman K; van Velzen M; Aarts L; Niesters M; Dahan A; Olofsen E
Br J Anaesth; 2020 Nov; 125(5):750-761. PubMed ID: 32838982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
